Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-075361

Chief Scientific Officer sold 37,352 shares at $12.00 ($448,254)

  • Chief Scientific Officer acquired 37,352 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-27 Exercise or conversion : show line 1 in the form +25,583 $1.92 $49,153 43,283 D
2022-06-27 Exercise or conversion : show line 2 in the form +11,769 $2.60 $30,599 55,052 D
2022-06-27 Sale : show line 3 in the form −37,352 $12.00 $448,254 17,700 D
Open-market sales · 37,352 sh · avg $12.00 · $448,254

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-06-27 Exercise or conversion : show line 4 in the form Stock Options (option to buy) −25,583 35,817 D
2022-06-27 Exercise or conversion : show line 5 in the form Stock Options (option to buy) −11,769 18,231 D
Loading xslF345X03/tm2219797-2_4seq1.xml…